Complementary mechanistic experiments further demonstrated that chemotherapy in combination with either PI3K or DNA-PK inhibitors significantly decreased chemotherapy-induced activation of AKT signaling, leading to a significant increase of DNA damage and apoptosis of inv(16)/KITD816Y AML cells. The gene discussed is PRKDC; the disease is acute myeloid leukemia.